Effects of Anticoagulants on Lipoprotein(A) Measurements with Four Commercial Assays

Clinical Chemistry and Laboratory Medicine

Volumn 34, Issue 3, 1996, Pages 251-256

  Lippi, Giuseppe ^a,b   Giampaolo, Lidia ^a,b   Guidi, Giancesare ^a,b  

^a Laboratorio di Chimica Clinica   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; APOLIPOPROTEIN B; CITRIC ACID; EDETIC ACID; HEPARIN; LIPOPROTEIN A;

ARTICLE; ASSAY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; INTERMETHOD COMPARISON; LIPOPROTEIN BLOOD LEVEL; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; SERUM;

ANTIBODY SPECIFICITY; ANTICOAGULANTS; CITRATES; EDETIC ACID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPARIN; HUMANS; LATEX; LIPOPROTEIN(A); NEPHELOMETRY AND TURBIDIMETRY; PARTICLE SIZE; REAGENT KITS, DIAGNOSTIC; REGRESSION ANALYSIS;

EID: 0029960872     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.1996.34.3.251     Document Type: Article

References (8)

1. Scanu A, Fless G. Lipoprotein(a). Heterogeneity and biological relevance. J Clin Invest 1990; 85: 1709-1715.
2. Marcovina S, Zhang Z, Gaur V, Albers J. Identification of 34 apolipoprotcin(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites. Biochem Biophys Res Commun 1993; 191: 1192-6.
3. Labour C, De Bacquer D, De Backer G, Vincke J, Muyldermans L, Vandckerckhove Y, et al. Plasma lipoprotein(a) values and severity of coronary artery disease in a large population of patients undergoing coronary angiography. Clin Chcm 1992; 38: 2261-6.
4. Fairer M, Game F, AJbers C, Neil A, Winocour P, Lacker M, et al. Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms. Arterioscler Thromb 1994; 14: 1272-83.
5. Brown S, Morisset J, Bocrwinkle E, Hutchinson R, Patsch W. The relation of lipoprotein(a) concentrations and apolipoprotein(a) phenotypes with asymptomatic atherosclerosis in sub subjects of the atherosclerosis risk in communities (ARIC) study. Artcrioscler Thromb 1993; 13: 1558-66.
6. Tyrrell J, Cooke T, Reilly M, Colgan M, Moore D, Shanik D, et al. Lipoprotein(a) and peripheral vascular disease. J Int Mod 1992; 232: 349-352.
7. Cooper G, Myers G, Smith S, Sampson E. Standardization of lipid, lipoprotcin and apolipoprotein measurements. Clin Chcm 1988; 34(B):B95-B105.
8. Behcshti I, Wessels L, Eckfeldt J. EDTA-Plasma vs scrum differences in cholesterol, high-density-lipoprotein cholesterol, and triglyceride as measured by several methods. Clin Chem 1994; 40: 2088-92.